Valuation : Rock Creek Pharmaceuticals Inc

Market Cap 2L 1L 1L 1L 2L 1.45Cr 2L 14.7L 6L 74.33L 6L 6L 2.37Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.72Cr 1.62Cr 1.48Cr 2.76Cr 189.71Cr 2.77Cr 19Cr 7.42Cr 97Cr 7.51Cr 7.35Cr 308.56Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.21%-3.11%+52.16%+91.64% 1,02400Cr
-2.22%-0.76%+51.08%+67.61% 66TCr
-2.99%-4.31%+18.59%+66.94% 45TCr
-0.88%+0.86%+29.77%+36.54% 35TCr
-10.89%-14.63%+9.27%+26.87% 29TCr
-1.38%-0.72%-0.79%+9.50% 25TCr
-10.08%-10.26%+40.32%+51.55% 24TCr
-2.32%-0.65%-15.84%-56.91% 21TCr
-2.88%-2.19%+26.54%+92.95% 19TCr
Average -3.61%+0.01%+23.46%+42.97% 40.75TCr
Weighted average by Cap. -2.42%-1.04%+32.70%+57.27%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.31Cr -3.12Cr -2.84Cr -5.31Cr -365.16Cr -5.33Cr -37Cr -14Cr -186.64Cr -14Cr -14Cr -593.93Cr -68.45L -58.85L -55.37L -50.53L -94.3L -65Cr -94.78L -6.56Cr -2.54Cr -33Cr -2.57Cr -2.51Cr -105.55Cr
Net Debt -45T -38.69T -36.4T -33.22T -61.99T -42.66L -62.31T -4L -2L -21.81L -2L -2L -69.39L 1.99Cr 1.71Cr 1.61Cr 1.47Cr 2.74Cr 188.25Cr 2.75Cr 19Cr 7.36Cr 96Cr 7.46Cr 7.29Cr 306.19Cr
Logo Rock Creek Pharmaceuticals Inc
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!